News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
107 Results
Type
Article (2)
Press Release (105)
Section
Business (42)
Deals (10)
Drug Development (20)
FDA (2)
Job Trends (1)
News (64)
Policy (1)
Tag
Alliances (5)
Approvals (2)
Best Places to Work (1)
Breast cancer (1)
Cancer (1)
Clinical research (16)
Data (2)
Earnings (33)
Events (36)
FDA (2)
IPO (10)
Medical device (1)
Medtech (1)
People (8)
Phase I (9)
Phase II (4)
Phase III (5)
Pipeline (1)
Preclinical (4)
Regulatory (1)
Southern California (1)
United States (23)
Date
Last 30 days (1)
Last 365 days (18)
2024 (18)
2023 (27)
2022 (18)
2021 (31)
2020 (8)
2019 (2)
2017 (3)
Location
California (1)
Europe (1)
Minnesota (23)
Southern California (1)
107 Results for "celcuity".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioMidwest
Celcuity To Participate in Jefferies Global Healthcare Conference
Celcuity Inc. today announced its participation in the Jefferies Global Healthcare Conference to be held in New York on June 4-6, 2024.
June 3, 2024
·
1 min read
Deals
Celcuity Announces Pricing of Underwritten Common Stock Offering
Celcuity Inc. today announced the pricing of an underwritten offering of 3,871,000 shares of its common stock at an offering price of $15.50 per share.
May 30, 2024
·
5 min read
Press Releases
Celcuity Inc. Reports Third Quarter Financial Results and Provides Corporate Update
November 14, 2024
·
13 min read
BioMidwest
Celcuity To Present at Upcoming Needham and Stifel Investor Conferences
Celcuity Inc. announced that Brian Sullivan, Chief Executive Officer, and Co-founder of Celcuity, will present and be available for one-on-one investor meetings at the following investor conferences:
April 4, 2024
·
2 min read
Press Releases
Celcuity Inc. Schedules Release of Third Quarter 2024 Financial Results and Webcast/Conference Call
November 8, 2024
·
2 min read
Business
Celcuity Inc. Reports First Quarter Financial Results and Provides Corporate Update
Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced financial results for the first quarter ended March 31, 2024 and other recent business developments.
May 15, 2024
·
11 min read
Press Releases
Celcuity Presents Overall Survival Data from Phase 1b Study Evaluating Gedatolisib in Combination with Palbociclib and Endocrine Therapy at the 2024 San Antonio Breast Cancer Symposium
December 12, 2024
·
5 min read
BioMidwest
Celcuity to Participate in Leerink Partners Global Biopharma Conference 2024
Celcuity Inc. announced its participation in the Leerink Partners Global Biopharma Conference 2024 to be held in Miami on March 11-13, 2024.
March 6, 2024
·
1 min read
Business
Celcuity Inc. Schedules Release of First Quarter 2024 Financial Results and Webcast/Conference Call
Celcuity Inc., a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, announced that it will release its financial results for the first quarter 2024 after the market closes on Wednesday, May 15, 2024.
May 8, 2024
·
1 min read
Business
Celcuity Appoints Eldon Mayer as Chief Commercial Officer
Celcuity Inc., a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, announced the appointment of Eldon Mayer as Chief Commercial Officer.
February 20, 2024
·
4 min read
1 of 11
Next
